NCT06064838 (FLALOC) is a NA clinical trial of Flavonoids in Long Covid19, sponsored by Guillermo Ceballos Reyes.

Who is sponsoring NCT06064838?

NCT06064838 is sponsored by Guillermo Ceballos Reyes.

What drugs are being tested in NCT06064838?

Interventions in NCT06064838: Flavonoids.

What condition does NCT06064838 study?

NCT06064838 studies Long Covid19, Fatigue Syndrome, Chronic.

Is NCT06064838 still recruiting?

NCT06064838 is currently completed. Last updated 1 October 2024.

Last reviewed 2024-10-01 · How we verify

NCT06064838: FLALOC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)

Completed NA Last updated 1 October 2024

What this trial tests

NA trial testing Flavonoids in Long Covid19 in 46 participants. Completed in 30 September 2024.

Timeline

1 August 2023

Primary endpoint
1 August 2024

30 September 2024

Quick facts

Lead sponsor	Guillermo Ceballos Reyes
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	46
Start date	1 August 2023
Primary completion	1 August 2024
Estimated completion	30 September 2024
Sites	1 location across Mexico

Drugs / interventions tested

Flavonoids — full drug profile →

Conditions studied

Long Covid19 — all drugs for Long Covid19 →
Fatigue Syndrome, Chronic — all drugs for Fatigue Syndrome, Chronic →

Sponsor

Guillermo Ceballos Reyes

Who can join

Adults 30 to 70, any sex, with Long Covid19 or Fatigue Syndrome, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study use a triple blind, placebo-controlled design enrolling male and female subjects between 30-70 yo to evaluate the effect of daily consumption of a cacao supplement on inflammation, endothelial damage, handgrip strength, fatigue scale and quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Cacao Flavonoids in Long COVID-19 Patients with Chronic Fatigue: FLALOC, a Placebo-Controlled Randomized Clinical Trial
Munguía L, Silva S, Villarreal F, Nájera N, et al · · 2026

Verify or expand the search:

Other trials of Flavonoids

Trials testing the same drug.

NCT02782455 — Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease · Phase 4 · completed

Other recruiting trials for Long Covid19

Currently open trials in the same condition.

NCT07140094 — Long-Covid-19 Alleviation Through Learning Mindfulness Study · NA · recruiting
NCT05890508 — Electro-acupuncture for Long Covid Neuropsychiatric Symptoms · NA · recruiting
NCT05741112 — The Long COVID-19 Wearable Device Study · NA · recruiting
NCT06633666 — Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06064838 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Guillermo Ceballos Reyes
Last refreshed: 1 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06064838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing